Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |